bioMérieux Stock Euronext Paris
Stocks
FR0010096479
Medical Equipment, Supplies & Distribution
OTC Markets Traded| Market Cap | 8.48B 9.76B 7.87B 7.26B 13.67B 931B 13.92B 93.17B 36.48B 463B 36.64B 35.84B 1,556B | P/E 2026 * |
17.6x | P/E 2027 * | 16x |
|---|---|---|---|---|---|
| Enterprise Value | 8.07B 9.29B 7.49B 6.91B 13.01B 887B 13.25B 88.69B 34.73B 440B 34.88B 34.11B 1,481B | EV / Sales 2026 * |
1.96x | EV / Sales 2027 * | 1.79x |
| Free-Float |
33.22% | Yield 2026 * |
1.45% | Yield 2027 * | 1.61% |
Last Transcript: bioMérieux
| 1 day | -0.27% |
| Manager | Title | Age | Since |
|---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 53 | 01/07/2023 |
| Director of Finance/CFO | 50 | 01/03/2018 | |
| Chief Tech/Sci/R&D Officer | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 51 | 15/12/2017 | |
| Director/Board Member | 66 | 01/01/2005 | |
| Director/Board Member | 61 | 30/05/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | +1.25% | - | - | 9.78B | |
| +5.75% | +1.43% | +237.13% | +292.45% | 19.1B | |
| +1.00% | -2.63% | +40.59% | +14.84% | 6.51B | |
| +6.71% | +2.85% | +255.36% | -21.43% | 5.88B | |
| +2.01% | +2.29% | -15.04% | -19.06% | 5.55B | |
| +3.21% | +2.81% | -45.46% | - | 4.41B | |
| 0.00% | +3.20% | -21.76% | -31.92% | 4.27B | |
| -6.84% | -15.30% | +57.97% | +75.47% | 4.14B | |
| +2.20% | +2.20% | -17.00% | -41.94% | 2.76B | |
| -6.70% | -16.32% | -47.98% | +153.78% | 1.44B | |
| Average | +0.71% | -1.11% | +49.31% | +52.77% | 6.01B | |
| Weighted average by Cap. | +2.30% | -2.05% | +111.79% | +115.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.12B 4.75B 3.83B 3.53B 6.65B 453B 6.77B 45.34B 17.75B 225B 17.83B 17.44B 757B | 4.34B 4.99B 4.03B 3.71B 7B 477B 7.12B 47.69B 18.67B 237B 18.75B 18.34B 796B |
| Net income | 482M 555M 448M 413M 778M 53.02B 792M 5.3B 2.08B 26.33B 2.09B 2.04B 88.55B | 525M 605M 488M 450M 847M 57.74B 863M 5.78B 2.26B 28.68B 2.27B 2.22B 96.43B |
| Net Debt | -408M -469M -379M -349M -658M -44.81B -670M -4.48B -1.75B -22.25B -1.76B -1.72B -74.84B | -731M -842M -679M -626M -1.18B -80.37B -1.2B -8.04B -3.15B -39.92B -3.16B -3.09B -134B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
